Log In
BCIQ
Print this Print this
 

TOL101

  Manage Alerts
Collapse Summary General Information
Company Tolera Therapeutics Inc.
DescriptionMurine mAb against the alpha beta T cell receptor (TCR)
Molecular Target Alpha beta T cell receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today